Inducing durable, protective immune memory against malaria
诱导针对疟疾的持久、保护性免疫记忆
基本信息
- 批准号:10545746
- 负责人:
- 金额:$ 80.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-16 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAfricaAntibodiesAreaAttenuatedB-LymphocytesBloodCapsid ProteinsCellsChemicalsCirculationClinicalClinical TrialsCommunicable DiseasesCountryCuesDataDevelopmentDiseaseEffector CellFutureGenerationsGoalsHumanImmuneImmune responseImmune systemImmunityImmunizationImmunologic MemoryImmunologyIndividualInfectionInflammatory ResponseInnate Immune ResponseInnate Immune SystemLicensingLymphocyteMaintenanceMalariaMalaria VaccinesMeasuresMediatingMemoryModelingMusOrganOutcomeParasitesParasitologyPersonsPlasmodiumPlasmodium falciparumPopulationPreventionProcessResearchResidenciesSamplingSentinelSporozoite vaccineSporozoitesSterilitySubunit VaccinesSurfaceSystemT-LymphocyteTechniquesTestingTimeTissuesVaccinationVaccine DesignVaccinesadaptive immune responsecircumsporozoite proteinclinically relevantexperienceinsightmalaria infectionmouse modelnovelprogramsresearch clinical testingresponsetoolvaccination strategyvaccine candidatevaccine developmentvaccine efficacyvaccine strategyvaccine trialvaccinology
项目摘要
Project Summary
The goal of generating a licensed vaccine that can provide long-lived immunity against infection with
Plasmodium falciparum, the protozoan parasite that causes the most lethal form of malaria, is yet unrealized.
Currently, the malaria vaccine candidate that has undergone the most extensive clinical testing is RTS,S, a
subunit vaccine based on the circumsporozoite protein (CSP), expressed on the surface of the infectious
sporozoite stage of the parasite. Yet, as seen with many other vaccine strategies, protection induced by
vaccination with RTS,S is not only suboptimal, it also wanes rapidly and there is negligible prevention of clinical
disease measured four years after immunization. A critical bottleneck for the generation of a protective malaria
vaccine is therefore understanding how to generate long-lived, Plasmodium-specific immune memory, especially
in people in malaria endemic countries. One promising approach is to gain greater insight into the immune
response to whole attenuated sporozoite vaccines, which can lead to the development of high levels
(>60%) of sterile immunity in malaria naïve subjects when tested by challenge using controlled human
malaria infection (CHMI) and has shown for the first time protection against infection in malaria-exposed
subjects in Africa. In this application, we will focus on three major questions that are critical to enhancing our
understanding of how immunity can be maintained after whole sporozoite vaccination: 1) how does the innate
immune response after sporozoite vaccination influence the development of long-lived adaptive memory, 2) how
does previous malaria infection alter the generation of sporozoite vaccine-induced memory and 3) how can we
harness recently characterized memory cell signatures in the blood to understand the maintenance of long-lived
immune cells in the tissues after sporozoite vaccination.
Our team consists of experts in immunology, vaccinology, parasitology and collaborators that conduct
sporozoite vaccine trials, and will pursue a fully integrated approach to address these questions. To answer
these questions, we will use both relevant human samples obtained from malaria-naïve and malaria pre-exposed
subjects who received different modes of whole sporozoite vaccination, as well as murine malaria models, which
allow immune system perturbations and access to target organs. We will combine our unique expertise with
novel tools and techniques to provide key insights into how immunological memory can be maintained after
immunization, which will broadly inform vaccination strategies for malaria, as well as other infectious diseases
for which vaccines are not currently available.
项目摘要
目标是生产一种获得许可的疫苗,能够提供对感染的长期免疫力
恶性疟原虫是导致最致命形式疟疾的原生动物寄生虫,目前还没有认识到这一点。
目前,经过最广泛临床试验的疟疾疫苗候选是RTS,S是一名
基于环子孢子蛋白(CSP)的亚单位疫苗,在感染性细胞表面表达
寄生虫的子孢子期。然而,正如许多其他疫苗策略所见,由
接种RTS,S不仅次优,而且消退快,临床预防微不足道
在免疫后四年测量疾病。保护性疟疾产生的关键瓶颈
因此,疫苗正在了解如何产生长寿的、疟疾特异性的免疫记忆,特别是
在疟疾流行国家的人身上。一种有希望的方法是更深入地了解免疫
对整个减毒子孢子疫苗的反应,这可能导致高水平的发展
(>;60%)疟疾幼稚受试者在使用受控人类进行挑战时的无菌免疫力
疟疾感染(CHMI),并首次显示出对接触疟疾的人的感染具有保护作用
非洲的受试者。在本应用程序中,我们将重点关注三个主要问题,这三个问题对于增强我们的
了解全程接种子孢子后如何维持免疫力:1)先天免疫是如何
接种子孢子后的免疫反应如何影响长寿适应性记忆的发展
以前的疟疾感染是否改变了子孢子疫苗诱导的记忆的产生?3)我们如何
Harness最近描述了血液中记忆细胞的特征,以了解长寿的维持
接种子孢子后组织中的免疫细胞。
我们的团队由免疫学、疫苗学、寄生虫学专家和合作者组成,他们进行了
目前正在进行子孢子疫苗试验,并将采取一种全面综合的办法来解决这些问题。回答
在这些问题上,我们将使用从疟疾获得的相关人体样本-幼稚和预先暴露的疟疾
受试者接受不同模式的全子孢子疫苗接种,以及小鼠疟疾模型,其中
允许免疫系统受到干扰并进入目标器官。我们将把我们独特的专业知识与
新的工具和技术,为如何保持免疫记忆提供关键见解
免疫接种,这将为疟疾和其他传染病的疫苗接种战略提供广泛的信息
目前还没有疫苗可供使用。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stefan HI Kappe其他文献
Stefan HI Kappe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stefan HI Kappe', 18)}}的其他基金
Parasite and host cell factors involved in the formation and persistence of Plasmodium vivax hypnozoites
寄生虫和宿主细胞因子参与间日疟原虫休眠子的形成和持续存在
- 批准号:
10564073 - 财政年份:2023
- 资助金额:
$ 80.27万 - 项目类别:
Biologically informed design of CD8+ T cell-dependent pre-erythrocytic stage malaria vaccines
CD8 T 细胞依赖性红细胞前阶段疟疾疫苗的生物学知情设计
- 批准号:
10341058 - 财政年份:2021
- 资助金额:
$ 80.27万 - 项目类别:
Biologically informed design of CD8+ T cell-dependent pre-erythrocytic stage malaria vaccines
CD8 T 细胞依赖性红细胞前阶段疟疾疫苗的生物学知情设计
- 批准号:
10558591 - 财政年份:2021
- 资助金额:
$ 80.27万 - 项目类别:
Assessing the determinants of durable protective immunity in SARS-CoV-2 infected human subjects
评估 SARS-CoV-2 感染人类受试者持久保护性免疫力的决定因素
- 批准号:
10265628 - 财政年份:2020
- 资助金额:
$ 80.27万 - 项目类别:
Assessing the determinants of durable protective immunity in SARS-CoV-2 infected human subjects
评估 SARS-CoV-2 感染人类受试者持久保护性免疫力的决定因素
- 批准号:
10375774 - 财政年份:2019
- 资助金额:
$ 80.27万 - 项目类别:
Inducing durable, protective immune memory against malaria
诱导针对疟疾的持久、保护性免疫记忆
- 批准号:
10084807 - 财政年份:2019
- 资助金额:
$ 80.27万 - 项目类别:
Molecular Determinants of Sporozoite / Host Cell Interactions
子孢子/宿主细胞相互作用的分子决定因素
- 批准号:
10192640 - 财政年份:2018
- 资助金额:
$ 80.27万 - 项目类别:
Refining Mendelian genetics of malaria parasites
完善疟疾寄生虫的孟德尔遗传学
- 批准号:
10216647 - 财政年份:2017
- 资助金额:
$ 80.27万 - 项目类别:
相似海外基金
Multi-component interventions to reducing unhealthy diets and physical inactivity among adolescents and youth in sub-Saharan Africa (Generation H)
采取多方干预措施减少撒哈拉以南非洲青少年的不健康饮食和缺乏身体活动(H 代)
- 批准号:
10106976 - 财政年份:2024
- 资助金额:
$ 80.27万 - 项目类别:
EU-Funded
Exploring the mental health and wellbeing of adolescent parent families affected by HIV in South Africa
探讨南非受艾滋病毒影响的青少年父母家庭的心理健康和福祉
- 批准号:
ES/Y00860X/1 - 财政年份:2024
- 资助金额:
$ 80.27万 - 项目类别:
Fellowship
Decolonization, Appropriation and the Materials of Literature in Africa and its Diaspora
非洲及其侨民的非殖民化、挪用和文学材料
- 批准号:
EP/Y024516/1 - 财政年份:2024
- 资助金额:
$ 80.27万 - 项目类别:
Research Grant
Exploring "Actionable Information" for Learning Improvement in Rural East Africa: A Positive Deviance Approach
探索东非农村地区学习改进的“可行信息”:积极偏差方法
- 批准号:
24K00390 - 财政年份:2024
- 资助金额:
$ 80.27万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Water stressed cities: individual choice, access to water and pathways to resilience in sub-Saharan Africa
缺水城市:撒哈拉以南非洲地区的个人选择、水资源获取和恢复力途径
- 批准号:
MR/X022943/1 - 财政年份:2024
- 资助金额:
$ 80.27万 - 项目类别:
Fellowship
Protecting Women from Economic shocks to fight HIV in Africa (POWER)
保护非洲妇女免受经济冲击,抗击艾滋病毒 (POWER)
- 批准号:
MR/Y003837/1 - 财政年份:2024
- 资助金额:
$ 80.27万 - 项目类别:
Fellowship
Tackling antimicrobial resistance across dentistry in Sub-Saharan Africa.
解决撒哈拉以南非洲牙科领域的抗菌素耐药性问题。
- 批准号:
MR/Y019695/1 - 财政年份:2024
- 资助金额:
$ 80.27万 - 项目类别:
Research Grant
ePowerCart - Affordable Mobile Clean Energy for Remote Communities in Rural Sub-Saharan Africa and India
ePowerCart - 为撒哈拉以南非洲和印度农村偏远社区提供经济实惠的移动清洁能源
- 批准号:
10076185 - 财政年份:2024
- 资助金额:
$ 80.27万 - 项目类别:
Collaborative R&D
The Open fracture National Evaluation (ONE) Study - South Africa: Improving outcomes in the care of open fractures in low resource settings
开放性骨折国家评估 (ONE) 研究 - 南非:改善资源匮乏地区开放性骨折的护理效果
- 批准号:
MR/Y00955X/1 - 财政年份:2024
- 资助金额:
$ 80.27万 - 项目类别:
Fellowship
Recognising & supporting informal mhealth in Africa through grassroots interventions (REIMAGINE)
认识
- 批准号:
MR/Y015614/1 - 财政年份:2024
- 资助金额:
$ 80.27万 - 项目类别:
Research Grant